Biohaven Ltd.

NYSE:BHVN

Biotechnology

Healthcare
$12.90 -1.62%

-$0.22 today

Market cap
$1.95B
Beta
3.31
P/E (TTM)
-3.1
EPS (TTM)
-$4.39
52W Low $7.48High $18.57

Volume 2.32M

Average 2.47M

BHVN Operating Margin

Operating income as a percentage of revenue, showing the profitability of core operations.

No reported Operating Margin figures are available to summarize.

Operating Margin history

Percent of revenue · from the income statement

No Operating Margin data reported for this period type.

Operating Margin vs competitors

How BHVN compares with its peers on the latest reported figures

BHVN Competitors Peer median
Operating Margin for BHVN and competitors
Company Period LTM level YoY 3-year change
XERSXeris Biopharma Holdings, Inc.LTM Mar 202611.4% +21.5 pp+82.9 pp
IMCRImmunocore Holdings plcLTM Mar 2026-7.6% +6.7 pp+18.3 pp
ABCLAbCellera Biologics Inc.LTM Sep 2026-298.0% +441.7 pp-333.6 pp
NTLAIntellia Therapeutics, Inc.LTM Mar 2026-636.6% +550.8 pp+227.4 pp
ZBIOZenas BioPharma, Inc.FY2025-2113.8% +1163.9 pp—
IMNMImmunome, Inc.FY2025-3084.8% +297.6 pp—
CLDXCelldex Therapeutics, Inc.LTM Sep 2026-298657.1% -288801.8 pp-14271.0 pp
BHVNBiohaven Ltd.FY2025— ——
PHVSPharvaris N.V.FY2025— ——
VERAVera Therapeutics, Inc.FY2025— ——
SIONSionna Therapeutics, Inc.FY2025— ——
Peer median (excluding BHVN) -636.6%+297.6 pp+18.3 pp

Competitors are the stored peer set for BHVN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue00000
Cost of Revenue00004.14M
Gross Profit0000(4.14M)
Gross Margin—————
Research & Development181.49M437.07M373.28M795.87M635.07M
Selling, General & Admin37.41M130.86M62.77M89.24M106.17M
Operating Expenses218.9M567.93M436.05M885.11M741.24M
Depreciation & Amortization1.39M1.39M6.91M7.86M9.92M
EBITDA(211.04M)(568.46M)(402.64M)(837.83M)(727.46M)
EBITDA Margin—————
Operating Income(218.9M)(567.93M)(436.05M)(885.11M)(745.38M)
Operating Margin—————
Interest Income0017.73M21.33M14.59M
Interest Expense00000
Other Income / Expenses6.47M(1.91M)26.5M39.42M8M
Income Before Tax(212.43M)(569.84M)(409.55M)(845.69M)(737.38M)
Pre-Tax Margin—————
Income Tax Expense1.37M438K(1.38M)735K1.44M
Net Income(213.8M)(570.28M)(408.17M)(846.42M)(738.82M)
Net Margin—————
EPS (Basic)(5.97)(12.75)(5.73)(9.28)(6.86)
EPS (Diluted)(5.97)(12.75)(5.73)(9.28)(6.86)
Weighted Avg Shares35.82M44.74M71.2M91.23M107.62M
Weighted Avg Shares (Diluted)35.82M44.74M71.2M91.23M107.62M

Biohaven Ltd.

NYSE:BHVN

Intrinsic Alpha fair value

Locked

Current Price

$12.90

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.